🇺🇸 FDA
Patent

US 6958342

Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

expired A61KA61K31/519A61P

Quick answer

US patent 6958342 (Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto) held by Neurocrine Biosciences, Inc. expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Oct 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/519, A61P, A61P5/02